drugset / Trial / NCT03363776
An Investigational Immuno-Therapy Study of Experimental Medication BMS-986277 Given Alone and in Combination With Nivolumab in Epithelial Cancers
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate experimental medication BMS-986277 given alone and in combination with Nivolumab in patients with epithelial cancers.
Timeline
- Start
- 2017-12-06
- Primary completion
- 2019-11-22
- Completion
- 2019-11-22
Outcome
Outcome not reported
Stopped (Business): “Business objectives have changed”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986277 | Unknown | — | — |
| Subject | Nivolumab | Monoclonal antibody | — | — |